  Giant prolactinomas represent a rare entity of pituitary tumors so that the management of these patients is still a prevalent challenge at present. Paying special attention to the treatment strategy and outcomes , we presented a large series of 42 cases looking forward to share our understanding and experience in management of these patients. Male patients accounted for 71.4 % of this series and were relatively younger ( 35.70 ± 2.42 vs. 52.00 ± 3.55 years , p = 0.0011) and harbored bigger tumors ( 14.57 vs. 7.74 cm